company

MEDISALG AS

3133 DUKEN

Return on Equity
7,83 %
Current Ratio
607,5
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue2 000
Net Income95 000
Total Assets1 215 000
Total Equity1 213 000
Income (NOK)2022
Revenue2 000
Expenditure11 000
Operating Profit−9 000
Financial Income204 000
Financial Costs100 000
Financial Balance104 000
Earnings Before Tax95 000
Tax0
Net Income95 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets1 215 000
Total Assets1 215 000
Total Retained Equity1 113 000
Total Equity1 213 000
Total Long-Term Debt0
Total Current Debt2 000
Total Equity and Debt1 215 000
Cash flow (NOK)2022
Sales Income2 000
Other Income0
Revenue2 000
Cost of Goods Sold2 000
Salary Costs0
Depreciation0
Impairment0
Expenditure11 000
Operating Profit−9 000
Financial Income204 000
Financial Costs100 000
Financial Balance104 000
Dividends0
Net Income95 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments1 164 000
Cash, Bank50 000
Total Current Assets1 215 000
Total Assets1 215 000
Total Equity1 213 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt2 000
Total Current Debt2 000
Total Equity and Debt1 215 000
Financial indicators2022
Return on Equity7,83 %
Debt-to-Equity Ratio0
Operating Profit Margin−450 %
Current Ratio607,5
Quick Ratio607,5
Equity Ratio1
Gross Profit Margin0 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English